Objectives: The objective of this study was to evaluate the use of antibiotics in treating upper respiratory tract infections (URTIs) in primary health centers in Kuwait and investigate the extent to which antibiotic use follows international guidelines. Subjects and Methods: A nationwide cross-sectional study was conducted with a sample size of 615 patients selected by using a multi-stage cluster sampling method. Of these, 270 patients had URTI and were included in the analysis. Data collection was done by observing the whole process starting from patient presentation and history taking to final diagnosis and treatment by the physicians. Results: Our study showed that about 135 (50%) of the patients with URTIs were given antibiotics, of which only 8 (6%) could be justified according to the NICE guidelines. However, prescriptions for 132 (98%) patients who were not given antibiotics could also be considered as evidence-based. Patients presenting with symptoms such as fever (OR = 2.7; p < 0.001) and sore throat (OR = 1.9; p < 0.01) were more likely be given antibiotics than those presenting without such symptoms. Furthermore, patients diagnosed with tonsillitis (OR = 25; p < 0.002), otitis media (OR = 9; p < 0.004), common cold (OR = 3; p < 0.049) or pharyngitis (OR = 2.7; p < 0.003) were more likely be given an antibiotic treatment as well. We also found that non-Kuwaitis were prescribed antibiotics more often than Kuwaitis (OR = 2.0; p < 0.005). Conclusion: This study showed a very high percentage of non-evidence-based prescriptions of antibiotics in Kuwait, and should be of great public health concern. Although overuse of antibiotics in primary care settings has been well reported from around the world, our finding of non-evidence-based use at 94% is of great public health concern since this may be linked primarily to the lack of evidence-based practice in Kuwait.

Keywords:
Antibiotic, Upper respiratory infections, Evidence practice, Primary health care, Antibiotic resistance, Kuwait
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.